Evidence map›Paper›PMID 25635034›Full record

Observational studyClinical journal of the American Society of Nephrology : CJASN2015

Progression of pediatric CKD of nonglomerular origin in the CKiD cohort.

Sahar A Fathallah-Shaykh, Joseph T Flynn, Christopher B Pierce, Alison G Abraham, Tom D Blydt-Hansen, Susan F Massengill, Marva M Moxey-Mims, Bradley A Warady, Susan L Furth, Craig S Wong

2 registry-linked trialsAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Clinical journal of the American Society of Nephrology : CJASN, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 61 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 1 pooled it
19.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00327860 recruitingnot on this map

Chronic Kidney Disease in Children Prospective Cohort Study (CKiD)

TypeobservationalSponsorJohns Hopkins Bloomberg School of Public HealthRan2003 to 2028Enrolled1,300ConditionsChronic Kidney Disease
NCT06266975 not yet recruitingnot on this mapstarted 2024, after this paper: background citation

Chronic Kidney Disease Patient in Chronic Myloied Leukemia

TypeobservationalSponsorSahar Mohammed GadRan2024 to 2026Enrolled40ConditionsChronic Myeloid Leukemia in RemissionArmsBiobsy from kidney
3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 1 synthesis or guideline pooled it, 120 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Sahar A Fathallah-ShaykhDue to the number of contributing authors, the affiliations are provided in the Supplemental Material. sfathallah@peds.uab.edu.
Joseph T FlynnDue to the number of contributing authors, the affiliations are provided in the Supplemental Material.
Christopher B PierceDue to the number of contributing authors, the affiliations are provided in the Supplemental Material.
Alison G AbrahamDue to the number of contributing authors, the affiliations are provided in the Supplemental Material.
Tom D Blydt-HansenDue to the number of contributing authors, the affiliations are provided in the Supplemental Material.
Susan F MassengillDue to the number of contributing authors, the affiliations are provided in the Supplemental Material.
Marva M Moxey-MimsDue to the number of contributing authors, the affiliations are provided in the Supplemental Material.
Bradley A WaradyDue to the number of contributing authors, the affiliations are provided in the Supplemental Material.
Susan L FurthDue to the number of contributing authors, the affiliations are provided in the Supplemental Material.
Craig S WongDue to the number of contributing authors, the affiliations are provided in the Supplemental Material.
University of Alabama · US

Funding

UNM HSC Clinical and Translational Science CenterUL1TR001449 · NCATS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI CAMPEN, MATTHEW J, PANDHI, NANCY · 2015 to 2024
$36.9M
Chronic Kidney Disease in Children Study (C-Kid)U01DK066174 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI SUSAN L. FURTH · 2003 to 2026
$25.1M
CKiD Cardiovascular Testing Travel SupplementU01DK066143 · NIDDK · CHILDREN'S MERCY HOSP (KANSAS CITY, MO) · PI Bradley Alan Warady · 2003 to 2026
$24.2M
The Kidney Disease in Children Data Management and Analysis Center (KIDMAC)U01DK066116 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI MUNOZ, ALVARO · 2003 to 2017
$17.9M
Central Biochemistry Laboratory of the CKiD ConsortiumU01DK082194 · NIDDK · UNIVERSITY OF ROCHESTER · PI SCHWARTZ, GEORGE J · 2008 to 2017
$3.5M
Patient Oriented Research in Pediatric Kidney DiseaseK24DK078737 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI FURTH, SUSAN L. · 2007 to 2016
$1.6M
NCATS NIH HHS UL1 TR001449NIDDK NIH HHS K24 DK078737NIDDK NIH HHS U01 DK066116NIDDK NIH HHS U01 DK066143NIDDK NIH HHS U01 DK066174NIDDK NIH HHS U01 DK082194NIDDK NIH HHS U01-DK082194NIDDK NIH HHS U01-DK66116NIDDK NIH HHS U01-DK66143NIDDK NIH HHS U01-DK66174
6 · The paper itself

Abstract

BACKGROUND AND

objectivesCongenital anomalies of the kidney and urinary tract and genetic disorders cause most cases of CKD in children. This study evaluated the relationships between baseline proteinuria and BP and longitudinal changes in GFR in children with these nonglomerular causes of CKD. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Urine protein-to-creatinine ratio, casual systolic and diastolic BP (normalized for age, sex, and height), and GFR decline were assessed in the prospective CKD in Children cohort study.

resultsA total of 522 children, median age 10 years (interquartile range, 7, 14 years) with nonglomerular CKD were followed for a median of 4.4 years. The mean baseline GFR in the cohort was 52 ml/min per 1.73 m(2) (95% confidence interval [95% CI], 50 to 54) and declined 1.3 ml/min per 1.73 m(2) per year on average (95%CI, 1.6 to 1.1). A 2-fold higher baseline urine protein-to-creatinine ratio was associated with an accelerated GFR decline of 0.3 ml/min per 1.73 m(2) per year (95% CI, 0.4 to 0.1). A 1-unit higher baseline systolic BP z-score was associated with an additional GFR decline of 0.4 ml/min per 1.73 m(2) per year (95% CI, 0.7 to 0.1). Among normotensive children, larger GFR declines were associated with larger baseline urine protein-to-creatinine ratios; eGFR declines of 0.8 and 1.8 ml/min per 1.73 m(2) per year were associated with urine protein-to-creatinine ratio <0.5 and ≥0.5 mg/mg, respectively. Among children with elevated BP, average GFR declines were evident but were not larger in children with higher levels of proteinuria.

conclusionsBaseline proteinuria and systolic BP levels are independently associated with CKD progression in children with nonglomerular CKD.

Indexed as

Blood PressureAdolescentAge FactorsBiomarkersChildCreatinineDisease ProgressionFemaleGlomerular Filtration RateHumansKidneyLongitudinal StudiesMaleNorth AmericaProspective StudiesProteinuriaBiomarkersCreatininechronic kidney diseasehypertensionproteinuriarenal progression

Identifiers

PMID25635034
PMCPMC4386256
OpenAlexW2099838214

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.